Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Abatacept, rituximab or tocilizumab3件: Abatacept,
Rituximab,
Tocilizumab		3件: D02596 ,
D02994 (Name: Rituximab),
D03203 		4件: CD80,
CD86,
IL6R,
MS4A1 💬		24件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46
2ABP 798 - Biosimilar to rituximab1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
3ABP 798 Biosimilar to Rituximab1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
4Administration of rituximab and methylprednisolone2件: Methylprednisolone,
Rituximab		7件: D00407 ,
D00751 ,
D00979 ,
D02994 (Name: Rituximab),
D05000 ,
D05001 ,
D05002 		2件: MS4A1,
NR3C1 💬		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 51
5Alemtuzumab and Rituximab2件: Alemtuzumab,
Rituximab		2件: D02802 ,
D02994 (Name: Rituximab)		2件: CD52,
MS4A1 💬		2件: , Hematopoietic cell lineage 💬1件: 60
6Alemtuzumab, Rituximab2件: Alemtuzumab,
Rituximab		2件: D02802 ,
D02994 (Name: Rituximab)		2件: CD52,
MS4A1 💬		2件: , Hematopoietic cell lineage 💬1件: 63
7Bendamustine, Rituximab2件: Bendamustine,
Rituximab		2件: D02994 (Name: Rituximab),
D07501 		1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 61
8Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine3件: Azathioprine,
Dexamethasone,
Rituximab		12件: D00238 ,
D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D02994 (Name: Rituximab),
D03033 		2件: MS4A1,
NR3C1 💬		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 35
9Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 85
10Dexamethasone and Rituximab2件: Dexamethasone,
Rituximab		10件: D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D02994 (Name: Rituximab)		2件: MS4A1,
NR3C1 💬		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 63
11Double-Blind Rituximab1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 51
12Dr. Reddy’s Rituximab (DRL_RI) 100mg1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
13Dr. Reddy’s Rituximab (DRL_RI) 500mg1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
14Eltrombopag combining rituximab2件: Eltrombopag,
Rituximab		1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 63
15Etanercepet, Rituximab, Abatacept, Tocilizumab, Sarilumab4件: Abatacept,
Rituximab,
Sarilumab,
Tocilizumab		4件: D02596 ,
D02994 (Name: Rituximab),
D03203 ,
D10161 		4件: CD80,
CD86,
IL6R,
MS4A1 💬		24件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46
16Experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab)1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 222
17GP2013 - A Proposed biosimilar rituximab1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
18IDEC-C2B8 (rituximab)1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
19Immunosuppressive treatment (eg, rituximab)1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 64
20Individualized dose of rituximab1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 49
21Intravenous Rituximab1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 66
22MabionCD20 (candidate biosimilar to rituximab)1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
23MabThera (Rituximab)1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬4件: 13, 46, 49, 53
24Mabthera or biosimilar Rituximab1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 61
25Mabthera or biosimilar rituximab product1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
26MabThera® (rituximab)1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
27Originator rituximab - Rituxan ® or MabThera ®1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
28Prednisone, low dose rituximab2件: Prednisone,
Rituximab		2件: D00473 ,
D02994 (Name: Rituximab)		2件: MS4A1,
NR3C1 💬		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 61
29RhTPO in combination with Rituximab2件: Recombinant Human Thrombopoietin,
Rituximab		1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 63
30Rituxan (INN: Rituximab), brand name in the United States1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
31Rituxan (INN: Rituximab), brand name in the US1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
32Rituxan (rituximab)1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 49
33Rituxan® (rituximab)1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
34Rituximab1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬49件: 6, 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 127, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331
35Rituximab (anti-CD20)1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 53
36Rituximab (Arm A)1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 43, 44
37Rituximab (Arm B)1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 43, 44
38Rituximab (EU)1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
39Rituximab (genetical recombination)1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 14
40Rituximab (MABTHERA® or RITUXAN®).1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 35, 61
41Rituximab (Mabthera®)1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 61
42Rituximab (Rituxan)1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 11
43Rituximab (RTX) and Azathioprine (AZA)2件: Azathioprine,
Rituximab		3件: D00238 ,
D02994 (Name: Rituximab),
D03033 		1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 65
44Rituximab (US)1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
45Rituximab - MabThera1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
46Rituximab 1g IV1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 162
47Rituximab [MabThera/Rituxan]1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 46, 63
48Rituximab [MabThera]1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
49Rituximab and Cyclophosphamide IV2件: Cyclophosphamide,
Rituximab		3件: D00287 ,
D02994 (Name: Rituximab),
D07760 		1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 35
50Rituximab and Hyaluronidase Human2件: Hyaluronidase,
Rituximab		4件: D02994 (Name: Rituximab),
D04455 ,
D04456 ,
D06604 		1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 331
51Rituximab combined with Omalizumab2件: Omalizumab,
Rituximab		2件: D02994 (Name: Rituximab),
D05251 		2件: FCER1A,
MS4A1 💬		5件: Asthma, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬1件: 162
52Rituximab Infusion1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 13, 222
53Rituximab IT1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
54Rituximab IV1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
55Rituximab konsentrat til infusjonsvaeske oppløsning 10 mg/ml1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
56Rituximab MabThera1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
57Rituximab, Mabthera1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 53
58Rituximab, MTX, folic acid2件: Folic acid,
Rituximab		2件: D00070 ,
D02994 (Name: Rituximab)		1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
59Rituximab, observational study amon patients with active RA1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
60Rituximab-EU+ Rituximab-Pfizer x 2 Courses1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
61Rituximab-Pfizer1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
62Rituximab-Pfizer (PF-05280586) x 3 courses1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
63Rituximab-US + Rituximab-Pfizer x 2 Courses1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
64Rituximab/ Mabthera1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 271
65SAIT101 (proposed rituximab biosimilar)1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
66SAIT101 (rituximab biosimilar)1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
67Standard dose of rituximab1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 49
68The Standard Steroid Treatment, Plasma Exchange and rituximab1件: Rituximab1件: D02994 (Name: Rituximab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 85